# SMT Healthcare Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/smt-healthcare-medical

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.smtworld.com
- Total disclosed funding: $14M
- Latest round: Series C (Sep 8, 2023)
- Investors on record: 10

## About

Based in Suzhou, China, and established in 2019, SMT Healthcare Medical is a medical equipment company that focuses on the blood purification field. The company is also a director of the China Blood Purification Materials Industry Association. SMT Healthcare Medical has established cooperation with the Blood Purification Membrane Materials Research Institute. It and Sichuan University jointly set up a joint research laboratory for polymer materials for blood purification. The company's ZOE(®) series of through-hemodialysis devices received three Class III medical device registration certificates in July, October and December 2022. In September 2023, SMT Healthcare Medical completed a series C+ funding.

The company provides hollow fiber membranes, including low and high flux hollow fiber membranes, plasma separator membranes, membrane oxygenator membranes, bacterial filter membranes, membranes for biopharmaceutical intermediates, and hollow fiber membranes for various professional filters. The products can be used in vaccines, cell therapy, antibody drugs, gene therapy and other biopharmaceutical-related fields, as well as blood purification.

## Funding rounds

- Series C, Sep 8, 2023, $14M — Neovision Capital, CCB Investment Funds Management, Baifu Capital
- Series C, Jun 14, 2023 — China International Capital Corporation, China Life Capital
- Series B, Jan 12, 2022 — CoStone Capital, BioTrack Capital, Sherpa Healthcare Partners, Suzhou Wuzhong Biomedical Industrial Park Investment
- Series A, Mar 30, 2021 — Riverhead Capital

## Investors

- Riverhead Capital (https://capitalatlas.ai/funds/riverhead-capital) — Series A
- CoStone Capital (https://capitalatlas.ai/funds/costone-capital) — Series B
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series B
- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Series B
- Suzhou Wuzhong Biomedical Industrial Park Investment — Series B
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series C
- China Life Capital — Series C
- Neovision Capital (https://capitalatlas.ai/funds/neovision-capital) — Series C
- CCB Investment Funds Management (https://capitalatlas.ai/funds/ccb-investment-funds-management) — Series C
- Baifu Capital (https://capitalatlas.ai/funds/baifu-capital) — Series C